Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Cervical Squamous Cell Carcinoma, Not Otherwise Specified”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04759911
What this trial is testing

Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer

Who this might be right for
Malignant Thyroid Gland NeoplasmPoorly Differentiated Thyroid Gland CarcinomaRecurrent Thyroid Gland Carcinoma+4 more
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT06597565
What this trial is testing

A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 43
Large-scale testing (Phase 3)Ended earlyNCT00113399
What this trial is testing

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery

Who this might be right for
Head and Neck Cancer
Radiation Therapy Oncology Group 15
Early research (Phase 1)Study completedNCT00006036
What this trial is testing

Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerLung CancerOvarian Cancer+1 more
NCIC Clinical Trials Group 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT07142421
What this trial is testing

Trifluridine/Tipiracil Combined With Anlotinib as Second-line Treatment for Recurrent and Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
First Affiliated Hospital of Zhejiang University 35
Testing effectiveness (Phase 2)WithdrawnNCT05668949
What this trial is testing

Phase I/II Open Label Study Evaluating the Safety and Efficacy of Combining STAT3 Inhibition (TTI-101) With Anti-PD-1 Therapy (Pembrolizumab) in Patients With Recurrent or Metastatic (RM) Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Head and Neck Squamous Cell Carcinoma
M.D. Anderson Cancer Center
Early research (Phase 1)Looking for participantsNCT07501650
What this trial is testing

Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer

Who this might be right for
Head and Neck CancerHead and Neck Small Cell CarcinomaMetastatic Head and Neck Cancer+1 more
Thomas Jefferson University 6
Testing effectiveness (Phase 2)Study completedNCT03650764
What this trial is testing

Ramucirumab + Pembrolizumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Washington University School of Medicine 43
Early research (Phase 1)Looking for participantsNCT06469008
What this trial is testing

BL-B16D1 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomasSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT06557889
What this trial is testing

Reduction in the Number of Chemotherapy Cycles in Combination With Pembrolizumab in First-line Treatment of PD-L1-positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinomas

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Institut Claudius Regaud 86
Testing effectiveness (Phase 2)Study completedNCT00030576
What this trial is testing

Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University Health Network, Toronto 51
Testing effectiveness (Phase 2)Study completedNCT01266447
What this trial is testing

Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Small Cell Carcinoma+5 more
National Cancer Institute (NCI) 27
Early research (Phase 1)Looking for participantsNCT07227168
What this trial is testing

STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma HNSCCNon-Small Cell Lung Cancer NSCLCEsophageal Cancer+6 more
Sutro Biopharma, Inc. 200
Testing effectiveness (Phase 2)UnknownNCT03830385
What this trial is testing

Paclitaxel (Albumin Bound),Bleomycin And Cisplatin Or Carboplatin for Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck

Who this might be right for
Squamous Cell Carcinoma Of The Head And Neck
Sun Yat-sen University 51
Not applicableStudy completedNCT04490564
What this trial is testing

Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaNon Small Cell Lung CancerMelanoma
Pharmassist Ltd 135
Large-scale testing (Phase 3)Active Not RecruitingNCT03769506
What this trial is testing

ASP-1929 Photoimmunotherapy (PIT) Study in Recurrent Head/Neck Cancer for Patients Who Have Failed at Least Two Lines of Therapy

Who this might be right for
Head and Neck Cancer
Rakuten Medical, Inc. 135
Not applicableUnknownNCT03713749
What this trial is testing

Robotic-assisted Esophagectomy vs. Video-Assisted Thoracoscopic Esophagectomy(REVATE) Trial

Who this might be right for
Esophageal Squamous Cell Carcinoma
Chang Gung Memorial Hospital 212
Not applicableStudy completedNCT00898664
What this trial is testing

DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 74
Testing effectiveness (Phase 2)Looking for participantsNCT06448026
What this trial is testing

Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity and HPV-negative Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Locally Recurrent Oral Cavity Squamous Cell Carcinoma
M.D. Anderson Cancer Center 17
Not applicableEnded earlyNCT02388932
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer

Who this might be right for
Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma+25 more
Case Comprehensive Cancer Center 3
Next Page